Nivolumab-induced polyarthritis

BMJ Case Rep. 2017 Dec 2:2017:bcr2017223387. doi: 10.1136/bcr-2017-223387.

Authors

Shoko Kodama¹, Koji Kurose², Tomoyuki Mukai¹, Yoshitaka Morita¹

Affiliations

¹ Department of Rheumatology, Kawasaki Medical School, Kurashiki, Japan.
² Department of Respiratory Medicine, Kawasaki Medical School, Kurashiki, Japan.

No abstract available

Keywords: drugs: musculoskeletal and joint diseases; musculoskeletal syndromes.

Publication types

Case Reports

MeSH terms

Anti-Inflammatory Agents / therapeutic use
Antibodies, Monoclonal / administration & dosage*
Antibodies, Monoclonal / adverse effects
Antineoplastic Agents / administration & dosage*
Antineoplastic Agents / adverse effects
Bursitis / chemically induced*
Bursitis / diagnostic imaging
Bursitis / drug therapy
Carcinoma, Non-Small-Cell Lung / drug therapy*
Female
Humans
Lymphatic Metastasis
Middle Aged
Nivolumab
Positron Emission Tomography Computed Tomography*
Prednisone / therapeutic use
Shoulder Joint / diagnostic imaging*
Shoulder Joint / pathology
Tenosynovitis / chemically induced
Tenosynovitis / diagnostic imaging*
Tenosynovitis / pathology
Treatment Outcome

Substances

Anti-Inflammatory Agents
Antibodies, Monoclonal
Antineoplastic Agents
Nivolumab
Prednisone